RSS-Feed abonnieren

DOI: 10.1055/s-0041-1741090
31-Phosphorus Magnetic Resonance Spectroscopy in Evaluation of Glioma and Metastases in 3T MRI
Autor*innen
Funding None.
Abstract
Background: 31-Phosphorus magnetic resonance spectroscopy (31-P MRS) has excellent potential for clinical neurological practice because of its noninvasive in-vivo assessment of cellular energy metabolism and the indirect evaluation of the phospholipid composition of the cell membrane, intracellular pH, and intracellular Mg2+ concentration.
Purpose: The aim of this study was to evaluate the metabolic characteristics of glioma and metastases using 31-P MRS and assess utility to differentiate both.
Study Type: Prospective study.
Population: Fifteen consecutive patients with brain tumor.
Field Strength/Sequence: Three-tesla magnetic resonance imaging/three-dimensional MRS imaging sequence.
Statistical Tests: Unpaired sample t-test, and one-way analysis of variance with Tukey's post-hoc test.
Results: Significantly decreased values of phosphomonoesters/inorganic phosphate (PME/Pi) in the tumor group (1.22 ± 0.72) compared with controls (2.28 ± 1.44) with a p-value of 0.041 were observed. There is a significant decrease in phosphocreatine (PCr)/Pi values (energy demand) in the tumor group (2.76 ± 0.73) compared with controls (4.13 ± 1.75) with a p-value of 0.050. Significant increase in Pi/adenosine triphosphate (ATP) was noted in tumor group (0.28 ± 0.09) compared with controls (0.22 ± 0.08) with p-value 0.049. Among tumor group, PME/PCr values were significantly decreased in gliomas (0.35 ± 0.17) than metastasis (0.58 ± 0.23) compared with controls with a p-value of 0.047. A significant decrease in PME/ATP was noted in gliomas (0.25 ± 0.12) than metastasis (0.41 ± 0.14) compared with controls with a p-value of 0.034. The tumor group exhibits alkaline pH (7.12 ± 0.10) compared with the normal parenchyma (7.04 ± 0.06) with a significant p-value of 0.025. Glioma and metastasis could not be differentiated with pH. However, the perilesional edema of glioma shows alkaline pH (7.09 ± 0.06) and metastasis shows acidic pH (7.02 ± 0.05) with a significant p-value of 0.030.
Conclusion: Our study provides new insight into the cellular constituents and pH of gliomas and metastases and results were significant in differentiation between these two. However, due to the additional high expense, it is available as a research tool in very few institutions in India.
Keywords
nuclear magnetic spectroscopy - 31-phosphorus multinuclear spectroscopy - glioma - metastasesPublikationsverlauf
Artikel online veröffentlicht:
10. Januar 2022
© 2022. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Mirkes C, Shajan G, Chadzynski G, Buckenmaier K, Bender B, Scheffler K. (31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results. MAGMA 2016; 29 (03) 579-589
- 2 Lei H, Zhu XH, Zhang XL, Ugurbil K, Chen W. In vivo 31P magnetic resonance spectroscopy of human brain at 7 T: an initial experience. Magn Reson Med 2003; 49 (02) 199-205
- 3 Ren J, Sherry AD, Malloy CR. (31)P-MRS of healthy human brain: ATP synthesis, metabolite concentrations, pH, and T1 relaxation times. NMR Biomed 2015; 28 (11) 1455-1462
- 4 Bonora M, Patergnani S, Rimessi A. et al. ATP synthesis and storage. Purinergic Signal 2012; 8 (03) 343-357
- 5 Verma A, Kumar I, Verma N, Aggarwal P, Ojha R. Magnetic resonance spectroscopy - revisiting the biochemical and molecular milieu of brain tumors. BBA Clin 2016; 5: 170-178
- 6 Morrison EA, Robinson AE, Liu Y, Henzler-Wildman KA. Asymmetric protonation of EmrE. J Gen Physiol 2015; 146 (06) 445-461
- 7 Hattingen E, Magerkurth J, Pilatus U. et al. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain 2009; 132 (Pt 12): 3285-3297
- 8 Cichocka M, Kozub J, Urbanik A. PH measurements of the brain using phosphorus magnetic resonance spectroscopy ((31)PMRS) in healthy men - comparison of two analysis methods. Pol J Radiol 2015; 80: 509-514
- 9 Dasgupta A, Gupta T, Jalali R. Indian data on central nervous tumors: a summary of published work. South Asian J Cancer 2016; 5 (03) 147-153
- 10 Davis FG, McCarthy BJ, Berger MS. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. Neuro-oncol 1999; 1 (03) 205-211
- 11 Schiff D. Single brain metastasis. Curr Treat Options Neurol 2001; 3 (01) 89-99
- 12 Hollingworth W, Medina LS, Lenkinski RE. et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 2006; 27 (07) 1404-1411
- 13 Cady EB, Hennig J, Martin E. Magnetic Resonance Spectroscopy in Imaging of the Central Nervous System of Neonates. New York: Springer Verlag;
- 14 Maintz D, Heindel W, Kugel H, Jaeger R, Lackner KJ. Phosphorus-31 MR spectroscopy of normal adult human brain and brain tumours. NMR Biomed 2002; 15 (01) 18-27
- 15 Kamble RB, Peruvumba N J, Shivashankar R. Energy status and metabolism in intracranial space occupying lesions: a prospective 31p spectroscopic study. J Clin Diagn Res 2014; 8 (11) RC05-RC08
- 16 Arnold DL, Emrich JF, Shoubridge EA, Villemure JG, Feindel W. Characterization of astrocytomas, meningiomas, and pituitary adenomas by phosphorus magnetic resonance spectroscopy. J Neurosurg 1991; 74 (03) 447-453
- 17 Heindel W, Bunke J, Glathe S, Steinbrich W, Mollevanger L. Combined 1H-MR imaging and localized 31P-spectroscopy of intracranial tumors in 43 patients. J Comput Assist Tomogr 1988; 12 (06) 907-916
- 18 Ha DH, Choi S, Oh JY, Yoon SK, Kang MJ, Kim KU. Application of 31P MR spectroscopy to the brain tumors. Korean J Radiol 2013; 14 (03) 477-486
- 19 Liu Y, Gu Y, Yu X. Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review. Quant Imaging Med Surg 2017; 7 (06) 707-726
- 20 Steen RG. Characterization of tumor hypoxia by 31P MR spectroscopy. AJR Am J Roentgenol 1991; 157 (02) 243-248
- 21 Kopp SJ, Krieglstein J, Freidank A, Rachman A, Seibert A, Cohen MM. P-31 nuclear magnetic resonance analysis of brain: II. Effects of oxygen deprivation on isolated perfused and nonperfused rat brain. J Neurochem 1984; 43 (06) 1716-1731
- 22 Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49 (23) 6449-6465
- 23 Hubesch B, Sappey-Marinier D, Roth K, Meyerhoff DJ, Matson GB, Weiner MW. P-31 MR spectroscopy of normal human brain and brain tumors. Radiology 1990; 174 (02) 401-409
- 24 Horská A, Barker PB. Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am 2010; 20 (03) 293-310
- 25 Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 1984; 2 (04) 343-366
- 26 Kerschbaumer J, Pinggera D, Steiger R. et al. Results of phosphorus magnetic resonance spectroscopy for brain metastases correlate with histopathologic results. World Neurosurg 2019; 127: e172-e178
- 27 Maintz D, Heindel W, Kugel H, Jaeger R, Lackner KJ. Phosphorus-31 MR spectroscopy of normal adult human brain and brain tumours. NMR Biomed 2002; 15 (01) 18-27
- 28 Okada Y, Kloiber O, Hossmann KA. Regional metabolism in experimental brain tumors in cats: relationship with acid/base, water, and electrolyte homeostasis. J Neurosurg 1992; 77 (06) 917-926
- 29 Oberhaensli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling RP, Radda GK. Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet 1986; 2 (8497): 8-11
- 30 Buonocore MH, Maddock RJ. Magnetic resonance spectroscopy of the brain: a review of physical principles and technical methods. Rev Neurosci 2015; 26 (06) 609-632
- 31 Andrade CS, Otaduy CG, Park EJ, Leite CC. Phosphorus-31 MR spectroscopy of the human brain: technical aspects and biomedical applications. Int J Curr Res Rev. 2014; 6: 41-57

